Ohr Pharmaceutical

Permanently closed
489 5th Ave Fl 28
New York, NY 10017

Ohr Pharmaceutical Inc., a biotechnology company based in New York City, focused on developing novel therapies for serious ocular diseases, particularly targeting wet age-related macular degeneration (wet AMD). Established in 2009, Ohr aimed to create alternatives to invasive treatments, exploring sustained-release drug delivery systems and small molecule drug candidates to improve patient outcomes in ophthalmology.

Despite initial promise, including a Phase IIb trial showing potential vision improvements, Ohr faced challenges with pivotal trial results that did not meet primary endpoints, leading to a strategic review and a subsequent reverse merger with NeuBase Therapeutics in 2019. This transition effectively dissolved Ohr's independent operations, shifting the focus from retinal disease solutions to a preclinical gene editing platform while its historical assets and narrative became part of the new entity.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkOhr Pharmaceutical

Partial Data by Foursquare.